MetaTrader
  • Marchés
  • Graphique & Idées
  • Algo
  • Nouvelles
  • Store
  • Courtiers
  • Télécharger
  • Calendrier Economique
  • Signaux de trading
  • Terminal Web
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
ImmunityBio, Inc. Common Stock

IBRX

#815
ImmunityBio, Inc. Common Stock
9.78
+3.93%
Secteur:
Base:
Devise de Profit:
Range quotidien
9.78
9.78
Range Annuel
1.83
12.43
Changement quotidien
+3.93%
Changement Mensuel
+63.00%
Evolution sur 6 mois
+312.66%
Changement Annuel
+213.46%
Clôture Précédente
9.41
Open
9.78
Bid
Ask
Low
9.78
High
9.78
Volume
189
  1. Marchés
  2. Actions des Marchés US
  3. Soins de Santé
  4. IBRX
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
Value 202020212022202320242025 TTM

Nouvelles

Investing Investing
IBRX
yesterday, 01:22
Simon, director, sells ImmunityBio (IBRX) shares worth $900k
Investing Investing
IBRX
2 days ago, 12:41
ImmunityBio completes enrollment in bladder cancer trial
Benzinga Benzinga
IBRX
2 days ago, 08:57
ImmunityBio Investors Rally Behind Cancer Trial Milestone - ImmunityBio (NASDAQ:IBRX)
Investing Investing
BAC-PS MSFT ORCL AMAT AXON
2026.02.25
Netflix and Palantir among market cap stock movers on Wednesday
Benzinga Benzinga
IBRX
2026.02.25
ImmunityBio Supersedes Expectations With Fivefold Revenue Increase - ImmunityBio (NASDAQ:IBRX)
Investing Investing
INTC ORCL AMZN EXPD HD
2026.02.24
AMD and Keysight Technologies among market cap stock movers on Tuesday
Investing Investing
C LLY WFC SCL TNDM
2026.02.23
Tesla, Oracle among market cap stock movers on Monday
Investing Investing
IBRX
2026.02.23
H.C. Wainwright raises Immunitybio stock price target to $15
Zacks Zacks
IBRX NTLA
2026.02.23
ImmunityBio (IBRX) Reports Q4 Loss, Beats Revenue Estimates
Investing Investing
C JPM-PL LLY ORCL EXPE
2026.02.23
American Express, Oracle among market cap stock movers on Monday
Investing Investing
IBRX
2026.02.23
Immunitybio Inc earnings beat by $0.05, revenue topped estimates
Benzinga Benzinga
IBRX
2026.02.23
ImmunityBio Shares Surge On 700% Revenue Growth Driven By Anktiva - ImmunityBio (NASDAQ:IBRX)

Marchés

  • Actions
  • Devises
  • Crypto-monnaies
  • Métaux
  • Matières premières

Graphique & Idées

  • Idées de Trading
  • Idées de Formations
  • Graphiques

MQL5 Community

  • Marché
  • Signaux
  • Forum
  • Articles
  • CodeBase

Nouvelles

  • Actions
  • Devises
  • Crypto-monnaies
  • Métaux
  • Matières premières

Courtiers

  • Tous les Courtiers
  • Forex
  • Actions
  • Métaux
MetaTrader 5
MQL5 Channels
Economic Calendar
Clause de Non-Responsabilité et Divulgation des Risques Conditions d'Utilisation Contacts et Demandes Légal
Copyright 2000-2026, MetaQuotes Ltd